Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus

NCT00220129 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Oesophageal Carcinoma

Interventions

DRUG: Epirubicin, Cisplatin, Capecitabine
PROCEDURE: Surgical Resection

Sponsor

Royal Marsden NHS Foundation Trust